BioSpace News Archive

Policy

Three Major Drug Distributors Could Settle Opioid Litigation for $18 Billion: Report

AmerisourceBergen, McKesson and Cardinal Health are in the midst of negotiations for a multi-billion settlement over litigation filed against each of the companies for their role in distributing opioid drugs across the country.

October 16, 2019
·
3 min read
·
Alex Keown
Drug Development

Novartis and Incyte’s JAK Inhibitor Jakafi Successful Against Graft-Versus-Host Disease

The primary endpoint of the trial was improving overall response rate at Day 28 with Jakafi compared to the best available therapy.

October 16, 2019
·
2 min read
·
Mark Terry
Policy

PixarBio CEO Made Wild Claims About Curing Paralysis, According to a Former Executive’s Testimony

Frank Reynolds, chief executive officer of PixarBio, made outlandish claims to investors and even compared himself to Apple’s Steve Jobs and Jesus Christ. Those were the claims of a witness made on the witness stand in an ongoing securities fraud trial.

October 16, 2019
·
3 min read
·
Alex Keown
Biotech Bay

Rho Presenting During the 14th Clinical Trials Innovation Programme (CTIP) in San Francisco

Rho, a full-service contract research organization 2019, taking place on October 22-23 in San Francisco, California.

October 16, 2019
·
1 min read
Drug Development

MetrioPharm AG: MetrioPharm AG Phase II Data in Psoriasis Show Dose-Response, Disease Modifying Activity and Outstanding Safety Profile

MetrioPharm AG, a clinical stage biopharmaceutical company, reports positive results from its recently completed Phase II dose finding study of MP1032 in psoriasis patients.

October 16, 2019
·
4 min read
Business

UM School of Pharmacy collaborates w/ tech startup emocha to offer clinical adherence solution

The Center for Innovative Pharmacy Solutions at the University of Maryland School of Pharmacy is collaborating with emocha Mobile Health to expand the company’s clinician-led adherence solution offering.

October 16, 2019
·
5 min read
Deals

Deepening Its Immune-Related Disease Pipeline, Alexion Buys Achillion for $930 Million

The deal is expected to close in the first half of 2020.

October 16, 2019
·
3 min read
·
Mark Terry
Pharm Country

Pfizer Looks to Fill Void for Chemo Drug After Teva Discontinues Its Generic Version

This shortage could force many treating physicians to begin making tough choices on how to address cancers in their patients.

October 16, 2019
·
2 min read
·
Alex Keown
Genetown

Versatope CEO Discusses Company’s Progress on Universal Flu Vaccine

Versatope Therapeutics received a leg up in its universal vaccine development efforts at the end of September with a $17.9 million grant from the National institute of Allergy & Infections Diseases.

October 16, 2019
·
3 min read
·
Alex Keown
BioSpace Global Roundup, Oct. 17

Companies from across the globe provide business and pipeline updates.

October 16, 2019
·
7 min read
·
Alex Keown